PTPRC and myasthenia gravis: In addition, studies have demonstrated an increased presence of immunosuppressive myeloid cells (CD45 + CD11b + PD-L1 +), myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs) in both peripheral blood and tumour tissues of MG patients.